MyFinsight
Home
Blog
About
Accounts receivable
$106,754K
(428.51%↑ Y/Y)
Marketable securities
$69,030K
(-71.68%↓ Y/Y)
Cash and cash
equivalents
$36,487K
(-54.14%↓ Y/Y)
Prepaid expenses
$11,904K
(10.47%↑ Y/Y)
Other current assets
$11,757K
(-39.64%↓ Y/Y)
Restricted cash
$225K
(-88.92%↓ Y/Y)
Total property and
equipment
$192,380K
(0.68%↑ Y/Y)
Total current assets
$236,157K
(-36.81%↓ Y/Y)
Property and equipment,
net
$98,452K
(-11.32%↓ Y/Y)
Operating lease
right-of-use assets
$43,867K
(-13.08%↓ Y/Y)
Other assets
$5,902K
(214.10%↑ Y/Y)
Restricted cash
$1,805K
(-11.08%↓ Y/Y)
Accounts receivable
$435K
(-72.54%↓ Y/Y)
Accumulated depreciation
and amortization
$93,928K
(17.33%↑ Y/Y)
Total assets
$386,618K
(-33.46%↓ Y/Y)
Total liabilities and
stockholders equity
$386,618K
(-33.46%↓ Y/Y)
Total liabilities
$314,853K
(-14.29%↓ Y/Y)
Total stockholders
equity
$71,765K
(-66.41%↓ Y/Y)
Accumulated deficit
-$1,193,369K
(-19.70%↓ Y/Y)
Accumulated other
comprehensive loss
-$875K
(-16.67%↓ Y/Y)
Royalty monetization
liabilities
$154,746K
(0.69%↑ Y/Y)
Total current
liabilities
$82,621K
(-30.88%↓ Y/Y)
Operating lease
liabilities
$61,596K
(-11.56%↓ Y/Y)
Deferred revenue
$15,404K
(-35.29%↓ Y/Y)
Other liabilities
$486K
(-26.81%↓ Y/Y)
Additional paid-in capital
$1,266,004K
(4.51%↑ Y/Y)
Common stock 0.0001 par
value 100,000 shares...
$5K
(0.00%↑ Y/Y)
Royalty monetization
liabilities
$26,765K
(-33.59%↓ Y/Y)
Accrued expenses and
other current...
$23,073K
(-35.11%↓ Y/Y)
Accounts payable
$15,546K
(-28.21%↓ Y/Y)
Deferred revenue
$9,882K
(-29.30%↓ Y/Y)
Operating lease
liabilities
$7,355K
(-8.62%↓ Y/Y)
Back
Back
Balance Sheet
REGENXBIO Inc. (RGNX)
REGENXBIO Inc. (RGNX)
source: myfinsight.com